Table 5.

Multivariable analysis of different remission criteria

	DAS28-ESR	DAS28-CRP	CDAI	SDAI	Boolean	CliDR
Sex
male
female	0•28 (0•17, 0•47)	0•50 (0•29, 0•88)	ns	ns	ns	0•46 (0•24, 0•88)
Age (years)	0•98 (0•97, 1•00)	0•986 (0•97,0•99)	ns	ns	ns	ns
Duration (months)	ns	1•003 (1•001, 1•005)	ns	ns	ns	ns
Comorbidities	0•62 (0•42, 0•92)	ns	ns	ns	ns	0•61 (0•44, 0•85)
EAM	0•58 (0•36, 0•95)	ns	ns	ns	ns	ns
Drug mode
csDMARD monotherapy
csDMARDs combination	0•51 (0•30, 0•88)	0•57 (0•33, 0•93)	ns	0•52 (0•30, 0•92)	ns	ns
csDMARDs with GC	0•40 (0•25, 0•64)	0•35 (0•22, 0•56)	0•54 (0•32, 0•91)	0•40 (0•24, 0•67)	0.47 (0.26, 0.85)	ns
GC monotherapy	0•19 (0•04, 0•91)	0•14 (0•05, 0•44)	ns	ns	ns	ns
b/tsDMARDs with or without csDMARDs	ns	ns	ns	2•00 (1•2, 3•4)	2.69 (1.50, 4.81)	2•4 (1•2, 4•8)

ns: no significance; All P < 0•05